Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Anticonvulsants Market?

In recent times, consistent expansion has been observed in the anticonvulsants market size. There is an expected increase from $18.85 billion in 2024 to $19.25 billion in 2025, signifying a compound annual growth rate (CAGR) of 2.1%. Factors contributing to this growth during the historic period involve the heightened incidence of epilepsy, advancements in diagnosis capabilities, wider-ranging indications, concentrated emphasis on personalized medicine, and elevated levels of awareness and education.

In the coming years, the anticonvulsants market is predicted to experience consistent growth. It is forecasted to expand to “$22.29 billion in 2029 with a compound annual growth rate (CAGR) of 3.7%. The expected growth in this period can be linked to the ongoing rise in epilepsy cases, broader applications in neuropsychiatry, the creation of new anticonvulsant drugs, enhanced focus on mental health and global health initiatives. Key trends predicted for this forecast period encompass the application and formulation of pediatric medicines, the shift towards extended-release formulations, the increasing acceptance of generic alternatives, amalgamation with digital health solutions, and neuroprotective effects research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10682&type=smp

Which Factor Is Shaping The Future Of The Anticonvulsants Market?

An increase in epilepsy cases is predicted to spur the expansion of the anticonvulsants market in the future. Epilepsy, a widespread disorder impairing the brain and frequently causing seizures, is a persistent non-infectious brain condition affecting people across all age groups. Anticonvulsants are drugs utilized to inhibit seizures in individuals with epilepsy. These medications manage epilepsy symptoms by disrupting the unusual electrical activity in the brain that induces seizures, although they do not necessarily provide a cure for this condition. For example, in February 2023, the World Health Organization, a Swiss-based UN agency responsible for global health, revealed that an average of 5 million people worldwide is diagnosed with epilepsy annually. High-income nations record an approximated 49 in every 0.1 million people being diagnosed with epilepsy annually, and the rates rise up to 139 in every 0.1 million in low- to middle-income countries. Thus, the growing incidence of epilepsy is fueling the upward trend of the anticonvulsants market.

What Is The Segment-Wise Breakdown Of The Anticonvulsants Market?

The anticonvulsants market covered in this report is segmented –

1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types

2) By Drug Generation: First Generation, Second Generation, Third Generation

3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages

4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder

5) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Pyrimidinediones: Stiripentol

2) By Benzodiazepines: Clonazepam, Diazepam, Lorazepam

3) By Fructose Derivatives: S-licarbazepine, Other Fructose Derivatives

4) By Aromatic Allylic Alcohols: Felbamate, Other Aromatic Allylic Alcohols

5) By Valproylamides: Valproic Acid, Divalproex Sodium

6) By Carboxamides: Lamotrigine, Other Carboxamides

7) By Bromides: Potassium Bromide, Sodium Bromide

8) By Other Types: Topiramate, Zonisamide, Ethosuximide

What Long-Term Trends Are Likely To Affect The Anticonvulsants Market?

One significant trend that is attracting attention in the anticonvulsants market is product development. Major market participants in the anticonvulsants field are dedicating their efforts towards inventing novel products in a bid to solidify their market position and obtain a competitive edge. An illustration of this is Lupin Limited, a pharmaceutical company based out of India, which introduced a new anticonvulsant drug application called Rufinamide tablets USP, 200 mg and 400 mg, in December 2022. Rufinamide is used in tandem with other medication to manage seizures in people suffering from an extreme form of epilepsy known as Lennox-Gastaut syndrome. This syndrome, which manifests during childhood, causes various types of seizures, as well as behavioral issues, and developmental lags.

Which Companies Hold The Largest Market Share In The Anticonvulsants Sector?

Major companies operating in the anticonvulsants market include Eisai Co Ltd., GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson Services Inc ., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm Group, Kannalife Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Mylan N.V., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, AstraZeneca plc, Glenmark Pharmaceuticals Limited, Laurus Labs Limited, Biocon Limited, Recordati S.p.A., Neurocrine Biosciences Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

How Does Regional Performance Compare Across The Anticonvulsants Industry?

North America was the largest region in the anticonvulsants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global anticonvulsants market report during the forecast period. The regions covered in the anticonvulsants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10682&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model